The Jackson Clinic

Jackson, Tennessee 38305

3 studies enrolling now · 35 studies all time

What they study most

Acute Gout, Adenoma, Adenoma Colon, Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Behavioral Measures of Tolerance, Bladder Cancer, Breast Cancer, Cancer, Cancer Colon

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass — Recruiting now
• Screening for High Frequency Malignant Disease — Running, not enrolling
• Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone — Completed
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• Global Prevalence of ATTR-CM in Participants With HFpEF — Stopped early
• Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Growth and Tolerance of a Partially Hydrolyzed Infant Formula — Completed
• Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images — Completed
• Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors — Completed
• Stool Collection Sub-Study of Exact Sciences Protocol 2018-01 — Completed
• Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD — Completed
• AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test — Completed
• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl — Completed
• Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence — Completed
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Diarrhea Predominant Irritable Bowel Syndrome in Females — Completed
• A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts — Stopped early
• Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US — Completed
• Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays — Stopped early
• Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance — Completed
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis — Completed